Cosmo Feilding Mellen is Managing Director at Spectrum Therapeutics UK, the medical arm of Canopy Growth Corporation, the world’s leading cannabis company
Previous to this, Cosmo has been a close collaborator of the Beckley Foundation – a UK think tank dedicated to drug policy reform – for almost a decade, and was involved in the formation of the Beckley-Exeter Cannabis Research Program in partnership with Exeter University.
